Trinity Biotech
TRIB
$1.75
Share price
-4.37%
Change (1 day)
59.09%
Change (1 year)
Categories
Trinity Biotech (TRIB) - Cash on Hand
Cash on Hand as of September 2023 : $6.26 M
According to Trinity Biotech
's latest financial reports the company has $6.26 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Trinity Biotech - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $6.57 M | -74.61% |
| 2021-12-31 | $25.91 M | -5.19% |
| 2020-12-31 | $27.32 M | 66.63% |
| 2019-12-31 | $16.4 M | -45.83% |
| 2018-12-31 | $30.27 M | -47.44% |
| 2017-12-31 | $57.6 M | -25.29% |
| 2016-12-31 | $77.1 M | -24.37% |
| 2015-12-31 | $0.10 B | 1020.12% |
| 2014-12-31 | $9.1 M | -59.21% |
| 2013-12-31 | $22.31 M | -70.22% |
| 2012-12-31 | $74.94 M | 5.43% |
| 2011-12-31 | $71.08 M | 22.56% |
| 2010-12-31 | $58 M | 854.29% |
| 2009-12-31 | $6.07 M | 17.25% |
| 2008-12-31 | $5.18 M | -40.41% |
| 2007-12-31 | $8.7 M | 208.4% |
| 2006-12-31 | $2.82 M | -71.45% |
| 2005-12-31 | $9.88 M | -55.66% |
| 2004-12-31 | $22.28 M | 8.38% |
| 2003-12-31 | $20.56 M | 254.08% |
| 2002-12-31 | $5.8 M | 9.95% |
| 2001-12-31 | $5.28 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $7.27 B | 116,159.38% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $8.07 B | 128,904.95% | 🇺🇸 USA |
 Danaher DHR | $7.03 B | 112,198.35% | 🇺🇸 USA |
 QuidelOrtho QDEL | $0.16 B | 2,572.10% | 🇺🇸 USA |
 OraSure Technologies OSUR | $0.29 B | 4,538.35% | 🇺🇸 USA |
 Chembio Diagnostics CEMI | $18.17 M | 190.35% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $1.60 B | 25,569.06% | 🇺🇸 USA |